Nir Drayman
0000-0003-4460-9558
The University of Chicago
1 paper found
Refreshing results…
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Missing publications? Search for publications with a matching author name.